Antiviral COVID-19 pill gains momentum as European Union medical agency begins reviewing the drug

The European Union's drug regulator is beginning to review Merck's antiviral COVID-19 drug. The drug has been called a potential 'game-changer' for the pandemic as the first oral pill for Covid.

Source: the Mail online | Health - October 26, 2021 Category: Consumer Health News Source Type: news